Company

Boehringer Ingelheim and Ruijin Hospital Launch "China Bronchiectasis Care Action" at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management
Boehringer IngelheimRuijin Hospital

Boehringer Ingelheim and Ruijin Hospital Launch “China Bronchiectasis Care Action” at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management

Boehringer Ingelheim ("BI") , together with Professor Qu Jieming's team at Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, jointly launched the "China Bronchiectasis Care Action" during…

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Hepalink Pharmaceutical's Enoparin Receives Argentina Approval for Thromboembolic Diseases
CVDHepalink Pharmaceutical

Hepalink Pharmaceutical’s Enoparin Receives Argentina Approval for Thromboembolic Diseases

Bio-heart's Iberis System Approved by NMPA for Hypertension Treatment
Angiocare Medical TechnologyBio-heart Biological Technology

Bio-heart’s Iberis System Approved by NMPA for Hypertension Treatment

Fosun Pharma's Tenapanor Approved in China for CKD Dialysis Patients
Fosun PharmaceuticalHKG: 2196

Fosun Pharma’s Tenapanor Approved in China for CKD Dialysis Patients

WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development
ADC / XDCCRO / CMO / CDMO

WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development

Show More